In recent years, blockbuster drugs, such as semaglutide (Ozempic, Rybelsus), tirzepatide (Mounjaro), and liraglutide (Victoza), have received growing attention as promising drugs for the treatment of type 2 diabetes and obesity
Were a minority in the community and because were a minority in the community, arguing that there is a better dietary approach to replace the benefits of these drugs is a minority position
Accessed October 10, 2023, PlushCare content is reviewed by MDs, PhDs, NPs, nutritionists, and other healthcare professionals
However, even these individuals typically see improvement as treatment continues
87 Their larger surface area and higher free energy enable them to remain stable against sedimentation, flocculation, coalescence, and creaming
Given this timeline, the cost difference between brand-name Ozempic and affordable alternatives becomes enormous: 18 months of brand-name costs $17,442 versus $3,582 for compounded alternatives, a difference of $13,860
